Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predictors of the corrected count increment after platelet transfusion, a secondary analysis of the PACER randomized controlled trial.
van Baarle FLF, van de Weerdt EK, van der Velden WJFM, Ruiterkamp RA, Tuinman PR, Ypma PF, van den Bergh WM, Demandt AMP, Kerver ED, Jansen AJG, Westerweel PE, Arbous MS, Determann RM, van Mook WNKA, Koeman M, Mäkelburg ABU, van Lienden KP, Vlaar APJ, Biemond BJ. van Baarle FLF, et al. Among authors: ypma pf. Am J Hematol. 2023 Nov;98(11):E305-E308. doi: 10.1002/ajh.27053. Epub 2023 Aug 21. Am J Hematol. 2023. PMID: 37605361 No abstract available.
Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial.
Bistervels IM, Buchmüller A, Wiegers HMG, Ní Áinle F, Tardy B, Donnelly J, Verhamme P, Jacobsen AF, Hansen AT, Rodger MA, DeSancho MT, Shmakov RG, van Es N, Prins MH, Chauleur C, Middeldorp S; Highlow Block writing committee; Highlow Investigators. Bistervels IM, et al. Lancet. 2022 Nov 19;400(10365):1777-1787. doi: 10.1016/S0140-6736(22)02128-6. Epub 2022 Oct 28. Lancet. 2022. PMID: 36354038 Clinical Trial.
Perioperative pharmacokinetic-guided factor VIII concentrate dosing in haemophilia (OPTI-CLOT trial): an open-label, multicentre, randomised, controlled trial.
van Moort I, Preijers T, Bukkems LH, Hazendonk HCAM, van der Bom JG, Laros-van Gorkom BAP, Beckers EAM, Nieuwenhuizen L, van der Meer FJM, Ypma P, Coppens M, Fijnvandraat K, Schutgens REG, Meijer K, Leebeek FWG, Mathôt RAA, Cnossen MH; OPTI-CLOT study group. van Moort I, et al. Lancet Haematol. 2021 Jul;8(7):e492-e502. doi: 10.1016/S2352-3026(21)00135-6. Lancet Haematol. 2021. PMID: 34171280 Clinical Trial.
Ixazomib, daratumumab and low-dose dexamethasone in intermediate-fit patients with newly diagnosed multiple myeloma: an open-label phase 2 trial.
Groen K, Stege CAM, Nasserinejad K, de Heer K, van Kampen RJW, Leys RBL, Thielen N, Westerman M, Wu KL, Ludwig I, Issa DE, Velders GA, Vekemans MC, Timmers GJ, de Boer F, Tick LW, Verbrugge A, Buitenhuis D, Cunha SM, van der Spek E, de Waal EGM, Sohne M, Sonneveld P, Nijhof IS, Klein SK, van de Donk NWCJ, Levin MD, Ypma PF, Zweegman S. Groen K, et al. Among authors: ypma pf. EClinicalMedicine. 2023 Aug 29;63:102167. doi: 10.1016/j.eclinm.2023.102167. eCollection 2023 Sep. EClinicalMedicine. 2023. PMID: 37680948 Free PMC article.
Predictive performance of pharmacokinetic-guided prophylactic dosing of factor concentrates in hemophilia A and B.
Goedhart TMHJ, Bukkems LH, Zwagemaker AF, Coppens M, Fijnvandraat K, Schols SEM, Schutgens REG, Eikenboom J, Heubel-Moenen FCJI, Ypma PF, Nieuwenhuizen L, Meijer K, Leebeek FWG, Mathôt RAA, Cnossen MH. Goedhart TMHJ, et al. Among authors: ypma pf. Res Pract Thromb Haemost. 2024 Mar 28;8(3):102397. doi: 10.1016/j.rpth.2024.102397. eCollection 2024 Mar. Res Pract Thromb Haemost. 2024. PMID: 38689619 Free PMC article.
Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients: Long-term Results of HOVON-126/NMSG 21.13.
Groen K, Schjesvold FH, van der Holt B, Levin MD, Seefat MR, Hansson M, Leys MBL, Regelink JC, Waage A, Szatkowski D, Axelsson P, Hieu Do T, Svirskaite A, van der Spek E, Haukas E, Knut-Bojanowska D, Ypma PF, Blimark CH, Mellqvist UH, van de Donk NWCJ, Sonneveld P, Klostergaard A, Vangsted AJ, Abildgaard N, Zweegman S. Groen K, et al. Among authors: ypma pf. Hemasphere. 2023 Aug 30;7(9):e940. doi: 10.1097/HS9.0000000000000940. eCollection 2023 Sep. Hemasphere. 2023. PMID: 37663673 Free PMC article. No abstract available.
Desmopressin in nonsevere hemophilia A: patient perspectives on use and efficacy.
Romano LGR, van Vulpen LFD, den Exter PL, Heubel-Moenen FCJI, Hooijmeijer HL, Coppens M, Fijnvandraat K, Schols SEM, Ypma PF, Smit C, Driessens MHE, Rosendaal FR, van der Bom JG, Gouw SC, Kruip MJHA. Romano LGR, et al. Among authors: ypma pf. Res Pract Thromb Haemost. 2023 Jun 17;7(5):100281. doi: 10.1016/j.rpth.2023.100281. eCollection 2023 Jul. Res Pract Thromb Haemost. 2023. PMID: 37601028 Free PMC article.
Patients' and health care providers' perspectives on quality of hemophilia care in the Netherlands: a questionnaire and interview study.
Brands MR, Haverman L, Muis JJ, Driessens MHE, van der Meer FJM, Goedhart G, Meijer S, de Jong M, van der Bom JG, Cnossen MH, Fijnvandraat K, Gouw SC; HiN6 Steering Group; SYMPHONY consortium@SYMPHONY_NL; SYMPHONY consortium. Brands MR, et al. Res Pract Thromb Haemost. 2023 Apr 23;7(4):100159. doi: 10.1016/j.rpth.2023.100159. eCollection 2023 May. Res Pract Thromb Haemost. 2023. PMID: 37346462 Free PMC article.
Platelet Transfusion before CVC Placement in Patients with Thrombocytopenia.
van Baarle FLF, van de Weerdt EK, van der Velden WJFM, Ruiterkamp RA, Tuinman PR, Ypma PF, van den Bergh WM, Demandt AMP, Kerver ED, Jansen AJG, Westerweel PE, Arbous SM, Determann RM, van Mook WNKA, Koeman M, Mäkelburg ABU, van Lienden KP, Binnekade JM, Biemond BJ, Vlaar APJ. van Baarle FLF, et al. Among authors: ypma pf. N Engl J Med. 2023 May 25;388(21):1956-1965. doi: 10.1056/NEJMoa2214322. N Engl J Med. 2023. PMID: 37224197 Clinical Trial.
Colorectal cancer screening in patients with inherited bleeding disorders: high cancer detection rate in hemophilia patients.
Kempers EK, van Kwawegen CB, de Meris J, Spaander MCW, Schols SEM, Ypma PF, Heubel-Moenen FCJI, van Vulpen LFD, Coppens M, van der Bom JG, Fijnvandraat K, Meijer K, Eikenboom J, Gouw SC, Leebeek FWG, Kruip MJHA. Kempers EK, et al. Among authors: ypma pf. J Thromb Haemost. 2023 May;21(5):1177-1188. doi: 10.1016/j.jtha.2022.12.004. Epub 2022 Dec 22. J Thromb Haemost. 2023. PMID: 36696188 Free article.
55 results